Topics

Companies Related to "Precise Base Editing Acetolactate Synthase Genes Confers Herbicide" [Most Relevant Company Matches] RSS

16:40 EST 21st February 2020 | BioPortfolio

Here are the most relevant search results for "Precise Base Editing Acetolactate Synthase Genes Confers Herbicide" found in our extensive corporate database of over 50,000 company records.

Showing "Precise Base Editing Acetolactate Synthase Genes Confers Herbicide" Companies 1–25 of 1,000+

Extremely Relevant

Beam Therapeutics Inc.

Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is usi...


Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is bac...

Relevant

Barrier Biotech Limited

Designer and manufacturer of animal healthcare product range.May 2000 saw the launch of our new Herbicide called Barrier H, designed to kill Ragwort, quickly and safely. Using only plant-derived non-toxic active ingredients, harvested from sustainable resources, it is the first environmental friendly herbicide licenced by the Pesticides Safety Directorate in the UK. See our website for more detail...


Editas Medicine

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology, with specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its genome editing technology into a novel class of human therapeutics...

Athenix provides genes

Athenix provides genes, proteins, traits, and transgenic organisms for multiple industry sectors including seed, agricultural chemicals, specialty chemicals, industrial enzymes, energy and feed.Our core technology platform is centered on high throughput microbial screens and focused genomic sequencing.Our product platforms include microbial strain improvement and genetic engineering of microbes an...

English Manager Science Editing

English Manager Science Editing is an Australian business that aims to provide a fast, efficient excellent-quality English language scientific editing service using the Internet. We use experienced freelance scientific editors with diverse backgrounds. Dr. Scott Butler - Managing EditorScott completed his Ph.D. in 1995 in the Department of Theoretical Chemistry at the University of Sydney. Subsequ...

Chromatin Inc.

Chromatin Inc. is developing and marketing innovative technology and products that can benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors. Its proprietary gene stacking technology can be used in any plant to simultaneously and precisely introduce multiple genes, and this technology has been licensed to leading agbiotech com...

Inscripta

Inscripta is a gene editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, single cell engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene editing tools (instruments, reagents, ...

Human Genome Sciences Incorporated

Human Genome Sciences, Inc. is engaged in the research and development of novel, proprietary pharmaceutical and diagnostic products based on the discovery and understanding of the medical utility of genes. Using automated, high-throughput gene sequencing technology, the Company has generated a very large collection of partial human gene sequences, which the Company believes correspond to most of t...

GenEdit, Inc.

GenEdit was founded to transform the delivery of gene and gene editing therapies. We have synthesized the NanoGalaxy™ library of polymers that can encapsulate RNA, DNA, protein and/or RNP. Through advanced screening methods, computational analysis and iterative medicinal chemistry, we have demonstrated efficient delivery of gene editing cargo to specific tissues. We seek development partners...

Shape Therapeutics, Inc.

Shape Therapeutics, Inc. is creating the world’s leading RNA and protein targeting platforms focused on the cure of human diseases. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). The RNAfix™ technology allows for the editing of RNA using natural human cell...

COBO Technologies

COBO Technologies is a fast-growing CRO specialised in services and products for quality control of genome editing applications in research and clinical fields. The company supports customers globally with detailed DNA mutation analysis and complexed protein expression profiling of cells, plants or animals modified with genome editing tools such as Meganucleases CRISPR-Cas9, ZFNs and TALENs.

Blu Genes Foundation

Blu Genes Foundation was established to advance research in gene therapy for genetic disorders, offering hope where currently there is none. This need is the driving force behind Blu Genes Foundation’s mission. Gene therapy research takes dedicated time and funding support to bring treatments from bench to bedside.

AltheaDx, Inc.

AltheaDx is a commercial stage molecular diagnostics company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx’s Research Services’ NGS portfolio includes pre-qualified panels such as AOP™150, Cancer Hotspo...

NeurAxon, Inc.

NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.

NeurAxon Inc.

NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.

Global Genes

Global Genes is a non-profit organization that operates as one of the leading rare disease patient advocacy groups in the world. Global Genes promotes the needs of the Rare Disease Community under a unifying symbol of hope—the Blue Denim Genes Ribbon™. The organization was born out of humble beginnings, emerging as a grassroots movement in 2009 comprise...

Trucode Gene Repair

Trucode Gene Repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. The elegance of triplex gene editing lies in its ability to harness natural, high-fidelity DNA repair mechanisms, and its independence from the requirement for exogenous nucleases and viral vectors. Trucode is hea...

Precise Engineering Ltd.

Precise Engineering Ltd. provides a comprehensive engineering services by developing designing and constructing tailor made solutions for the critical systems in your facility.We serve the following industries: Pharmaceuticals, Bio - technologies, Chemical, Medical devices, Electronics, Electro- Optics.

RepairGenes

The aim of the repairGenes site is to be a source of information about DNA repair genes and a useful resource for research on DNA repair.At the moment, the site contains information about a number of DNA repair genes from a set of selected species. The information is organised by organism and by biological process term as defined by the Gene Ontology (GO) project. The coverage of DNA repair genes ...

Evi-Base

Evi-Base provides evidence-based programs and solutions for chronic disease self-management and prevention. Quickly becoming one of the nation’s preeminent companies in its field, Evi-Base works with hospitals, health plans, health systems and ACOs to help patients and members better understand how to live with their disease, thus providing improved...

Pantec Biosolutions AG

Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.® (Precise Laser EpidermAl SystEm) technology has been developed for:

Hyseq Incorporated

Hyseq, Inc. is a biopharmaceutical company with a growing pipeline of product candidates in its genomics-based HyProfileportfolio. The primary product candidates are expressed proteins of novel rare genes discovered through applications of the Company's proprietary HyX platform in conjunction with work performed by its Functional Genomics, Protein Purification and Bioinformatics Groups. The Compan...

transparent

The company transparent, the translation company located in the heart of Berlin, in the central district of Schöneberg, provides translations into and out of more than 25 languages. Our combination of translation and text services means we can supply services ranging from translations, editing and proofreading in German and other langugages to layout and editing of the final documents. Another ar...

Chlorogen

The idea that culminated in the founding of Chlorogen in 2002 began in the mid 1980s. That's when molecular biologist Professor Henry Daniell became interested in the developing field of plant biotechnology. While he recognized the tremendous potential for plants to produce beneficial novel proteins for foods, medicines and industrial uses, he questioned whether there was a risk that foreign genes...


More From BioPortfolio on "Precise Base Editing Acetolactate Synthase Genes Confers Herbicide"

Quick Search

Corporate Database Quicklinks